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Abstract
Research indicates opioid antagonists can reduce alcohol drinking in rodents. However, tests 
examining the effects of opioid antagonists on ethanol seeking and relapse behavior have been 
limited. The present study examined the effects of two opioid antagonists on ethanol maintenance, 
seeking, and relapse responding by alcohol-preferring (P) rats. Adult P rats were self-trained in 
two-lever operant chambers to self-administer 15% (vol/vol) ethanol on a fixed-ratio 5 (FR5) 
versus water on a FR1 concurrent schedule of reinforcement in daily 1-h sessions. After 10 weeks, 
rats underwent extinction training, followed by 2 weeks in their home cages. Rats were then 
returned to the operant chambers without ethanol or water to measure responses on the ethanol and 
water levers for four sessions. After a subsequent 2 weeks in the home cage, without access to 
ethanol, rats were returned to the operant chambers with ethanol and water available. Effects of 
antagonists on maintenance responding were tested after several weeks of daily 1-h sessions. 
Naltrexone (NAL; 1–10 mg/kg, subcutaneously [s.c.]; n = 8/dose), LY255582 (LY; 0.03–1 mg/kg, 
s.c.; n = 8/dose), or vehicle were injected 30 min before the first session (in the absence of 
ethanol), following 2 weeks in their home cages, and for four consecutive sessions of ethanol self-
administration under maintenance and relapse conditions. Both NAL and LY reduced responses 
on the ethanol lever without any fluids present, and ethanol self-administration under relapse and 
on-going drinking conditions, with LY being more potent than NAL. Both NAL and LY were less 
effective in reducing responding in the absence of ethanol than in reducing ethanol self-
administration. Overall, the results indicate that the opioid system is involved in mediating ethanol 
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seeking, and ethanol self-administration under relapse and on-going alcohol drinking, but that 
different neurocircuits may underlie these behaviors.
Keywords
Ethanol reinforcement; Pavlovian Spontaneous Recovery; Alcohol deprivation effect; Alcohol 
seeking; Operant; Alcohol relapse
Introduction
Preclinical and clinical data implicate the endogenous opioid system in alcohol dependence 
(Modesto-Lowe and Fritz, 2005; Oswald and Wand, 2004). Preclinically, naltrexone (NAL), 
an opioid receptor subtype nonspecific antagonist, has been shown to decrease alcohol 
consumption in nonhuman primates (Boyle et al., 1998; Kornet et al., 1991; Myers et al., 
1986; Williams et al., 1998), in rat lines selectively bred for high-alcohol consumption 
(Gilpin et al., 2008; Koistinen et al., 2001; Rezvani et al., 2007; Sabino et al., 2006; Sable et 
al., 2006; Zalewska-Kaszubska et al., 2008), in rat lines selectively bred for characteristics 
other than alcohol consumption (Pellicano and Sadile, 2006), in nonselected genetically 
heterogenous rats (Czachowski and Delory, 2009; Ji et al., 2008; Kiefer et al., 2005; Kuzmin 
et al., 2008; Mhatre et al., 2004; Oliva and Manzanares, 2007; Walker and Koob, 2008), and 
in inbred C57BL/6J (B6) mice (Escher and Mittleman, 2006; Grahame et al., 2000; Kamdar 
et al., 2007; Kim et al., 2004). Among most double-blind controlled clinical trials, NAL has 
demonstrated a consistent yet modest effect in reducing heavy alcohol consumption in both 
alcohol-dependent (Assanangkornchai and Srisurapanont, 2007; Krishnan-Sarin et al., 2007; 
Pettinati et al., 2006) and nondependent (Tidey et al., 2008) individuals. In addition to the 
reduction of heavy drinking, NAL was found to facilitate the maintenance of abstinence, and 
the prevention of relapse to heavy drinking (O’Malley et al., 1992; Rösner et al., 2008; 
Spanagel and Kiefer, 2008).
Operationally, ethanol-seeking behavior is a result of a prior history of chronic ethanol 
drinking that is expressed in the absence of alcohol, in response to ethanol-associated cues, a 
priming dose of ethanol, or stress. In several studies, NAL has blocked or decreased seeking 
induced by ethanol-associated cues, and by a priming dose of ethanol, but not by stress. 
Cue-induced ethanol-seeking behavior of Long-Evans rats was blocked with administration 
of 10 mg/kg dose of NAL (Williams and Schimmel, 2008), and reduced with a 0.3 mg/kg 
dose of NAL (Burattini et al., 2006). In Wistar rats, a 1-mg/kg dose of NAL was sufficient 
to block cue-induced ethanol-seeking behavior (Ciccocioppo et al., 2003; Dayas et al., 2007; 
Liu and Weiss, 2002). In Wistar rats, NAL blocked reinstatement of ethanol responding 
induced by a priming dose of ethanol, but not by stress (Lê et al., 1999; Liu and Weiss, 
2002). Bäckström and Hyytia (2004) indicated that NAL administered to Long-Evans rats, 
decreased reinstatement induced by a priming dose of ethanol. Overall, the data indicate that 
the opioid system is involved in cue-induced and ethanol-induced alcohol-seeking behavior, 
as measured in a reinstatement model using nonselected lines of rats.
Relapse can be defined as a return to drug use or drinking after a period of abstinence. It has 
been demonstrated that NAL decreased ethanol-consuming behaviors in animal models of 
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alcohol relapse. The alcohol deprivation effect (ADE) is a commonly used animal model of 
relapse behavior (Rodd et al., 2004). The ADE is defined as a temporary increase in the 
voluntary intake of ethanol solutions when ethanol is restored following a period of alcohol 
deprivation (Sinclair and Senter, 1967, 1968). The ADE can be blocked by NAL in Wistar 
rats (Heyser et al., 2003; Hölter and Spanagel, 1999; Kuzmin et al., 2007), in Fawn Hooded 
rats (Cowen et al., 1999), in high ethanol-preferring rats (Mormede et al., 2004), and in 
rhesus monkeys (Kornet et al., 1991). These findings indicate that the opioid system is 
involved in ethanol relapse drinking and self-administration.
Although several studies have been carried out to determine the effect of NAL on ethanol 
seeking, none have been carried out using Pavlovian Spontaneous Recovery (PSR) as a 
model of ethanol-seeking behavior. PSR is the recovery of responding in the absence of the 
previously trained reward that is observed following a period of rest after extinction 
(Domjan and Burkhard, 1982; Macintosh, 1977). One beneficial aspect of the PSR 
procedure is that the spontaneous responding operant behavior occurs in the absence of drug 
administration following prolonged periods of abstincence. Because the behavior occurs 
within the environment previously associated with drug availability in the absence of drug 
reinforcement, and following a prolonged drug-free period, all responses are thought to be 
intrinsically motivated (Pavlov, 1927). Thus, the persistence of PSR in the absence of 
reward can be conceived as a suitable paradigm to assess drug-seeking behavior in animals 
(Rodd et al., 2004), and in modeling the compulsive nature of drug abuse in humans (Anton, 
1999). The present study is the first to determine the effect of NAL or LY255582 (LY) on 
the robust PSR observed in alcohol-preferring (P) rats.
Although studies have been carried out to determine the role of the opioid system in alcohol-
seeking and relapse behaviors (Burattini et al., 2006; Ciccocioppo et al., 2002, 2003; 
Marinelli et al., 2007), no opioid antagonist studies have been carried out with P rats using 
the PSR test. With respect to relapse, one study carried out in selectively bred P rats (Badia-
Elder et al., 1999) reported a reduction with naloxone, whereas the other study carried out in 
the inbred P rat strain (Rezvani et al., 2009) reported no effect with NAL. However, neither 
study examined the effects of the opioid antagonist under operant conditions.
The objectives of the present study were to determine the effects of NAL on robust alcohol-
seeking and relapse behaviors following prolonged deprivation, and assess their effect on 
maintenance of alcohol self-administration under operant conditions and to compare these 
effects with a novel nonspecific opioid antagonist, LY.
Materials and methods
Animals
Adult female selectively bred P rats from the 53rd to 54th generations weighing 250–325 g 
at the start of the experiment were used. P rats were obtained from breeding colonies on 
campus. Female P rats were used throughout the study because females were available when 
the study was initiated. Although estrous cycle was not monitored, previous studies carried 
out with female P rats, in which ethanol motivated responding (ethanol consumption and 
intracranial ethanol self-administration) was monitored over a 2–4-week period, indicated no 
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significant day-to-day alterations in responding, suggesting little influence of the estrous 
cycle on motivated responding by female P rats (Rodd et al., 2005; Sable et al., 2006; 
Toalston et al., 2008). Rats were maintained on a 12-h reversed light-edark cycle (lights off 
at 0900 h). Food and water were available ad libitum throughout the experiment, except 
during operant testing. The animals used in these experiments were maintained in facilities 
fully accredited by the Association for the Assessment and Accreditation of Laboratory 
Animal Care. All research protocols were approved by the Institutional Animal Care and 
Use Committee (Indiana University School of Medicine) and are in accordance with the 
guidelines of the Institutional Care and Use Committee of the National Institute on Drug 
Abuse, National Institutes of Health, and the Guide for the Care and Use of Laboratory 
Animals (Institute of Laboratory Animal Resources, Commission on Life Sciences, National 
Research Council 1996).
Drug preparation
LY was provided by the Eli Lilly Company (Indianapolis, IN). LY was dissolved in lactic 
acid and pH adjusted to 5.00 with 1 N NaOH. NAL HCL was obtained from Sigma (St. 
Louis, MO) and was dissolved in saline. NAL and LY were administered subcutaneously 30 
min prior to the test session. NAL was given in doses of 1, 5, or 10 mg/kg; LY was given in 
doses of 0.03, 0.1, 0.3, or 1.0 mg/kg. Doses for NAL were chosen based on background 
studies carried out in adolescent and adult P rats showing that doses as high as 20 and 30 
mg/kg were needed to decrease ethanol consumption. These doses did not alter water and 
food intake. In fact, in the adolescent rats, there was a compensatory increase in water 
intake, indicating a decreased preference for ethanol with the total volume of fluid 
consumed remaining unaffected (Sable et al., 2006). The rationale for using the doses for 
LY that were used stem from studies indicating that doses as high as 1 mg/kg (the highest 
dose used in our study) did not decrease food intake in obese zucker rats (Statnick et al., 
2003).
Operant apparatus
Ethanol self-administration (in 60-min sessions) was conducted in standard two-lever 
experimental chambers (Coulbourn Instruments) contained within ventilated, sound-
attenuated enclosures as previously described (Rodd-Henricks et al., 2002a, 2002b).
Operant training
Without any prior training, exposure to the experimental setup, or access to ethanol, rats 
were placed into the operant chambers. The ethanol (15% vol/vol) and water levers were 
maintained on a fixed-ratio 1 (FR1) schedule of reinforcement for the first 5 weeks (Fig. 1). 
Subsequently, the reinforcement schedule on the ethanol lever was increased to FR3 in 
weeks 6 and 7 and to FR5 in weeks 8–10 (Fig. 1). The response requirement was increased 
to demonstrate that ethanol was a more potent reinforcer than water, and was also increased 
so as to have a high baseline level of responding to allow for determining dose-dependent 
reductions in responding. Water was always reinforced on an FR1 schedule. The FR1 
schedule was maintained for water because increasing the requirement would result in a 
further reduction in the low level of responding for water.
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Extinction
After the P rats had established stable levels of responding, rats were placed into the operant 
chambers during the 60-min period, but neither water nor ethanol was available. The 
delivery system operated exactly as during acquisition; rats still received the auditory 
stimulus of the dipper raising and the visual cue of the small light being illuminated above 
the dipper trough. Rats were exposed to the extinction sessions for seven consecutive 
sessions (Fig. 1). Similar methodology was used by Rodd et al. (2006).
PSR testing
After extinction training, all rats were maintained in their home cages for 14 days (Fig. 1). 
Following this 2-week period, rats were returned to the operant chambers for PSR testing. 
Similar to the extinction phase of the experiment, both the ethanol and water troughs were 
empty. Except for the absence of fluids, the delivery system operated exactly as during 
acquisition. Rats were exposed to the PSR testing for 4 consecutive days (Fig. 1). Similar 
methodology was used by Rodd et al. (2006).
Relapse
Following the PSR phase of the experiment, all rats were again maintained in their home 
cages for 14 days (Fig. 1). Rats were then transferred to the operant chambers with both 
ethanol and water available for the 60-min sessions. The ethanol lever was maintained on an 
FR5 schedule and the water lever on an FR1 schedule.
Maintenance
For the NAL study, a separate group of rats were processed through the same experimental 
technique but only received NAL during the maintenance period.
For the LY study, following 30 consecutive daily sessions of operant access to 15% ethanol 
and water (Fig. 1), the effects of LY on ethanol maintenance responding were tested. This 
number of sessions was carried out to establish on-going ethanol self-administration and 
minimize any possible carryover effect of LY.
NAL administration on ethanol PSR/ADE/maintenance responding
Following acquisition and extinction training, 32 adult P female rats were randomly 
assigned to one of four groups. Rats received NAL or saline 30 min prior to the all four PSR 
test sessions. These same rats were also used to test the effects of NAL during relapse 
responding, using a counterbalanced design (i.e., rats that were administered NAL or saline 
during the PSR test sessions were randomly assigned to separate groups that received NAL 
or saline during relapse).
The separate group of rats in the NAL study that were tested only during maintenance were 
also taken through extinction, PSR testing, and relapse drinking. Following 30 consecutive 
operant sessions after relapse testing, rats received NAL or saline 30 min prior to four 
consecutive operant sessions (Fig. 1). Rats then received 8 consecutive sessions of ethanol 
operant access to assess carryover effects of NAL (Fig. 1).
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LY administration on ethanol PSR/ADE/maintenance responding
Following acquisition and extinction training, 40 adult female P rats were randomly 
assigned to one of five groups. Rats received LY or vehicle 30 min prior to the all four PSR 
test session. These same rats were also used to test the effects of LY during relapse and 
maintenance responding, using a counterbalanced design (i.e., rats that were administered 
LY or vehicle during the PSR test sessions were randomly assigned to separate groups that 
received LY or vehicle during relapse, with doses counterbalanced similarly for the 
maintenance phase as well). For relapse testing, rats received LY or vehicle 30 min prior to 
the initial four reinstatement sessions. Following 30 consecutive operant sessions, the rats 
received LY or vehicle 30 min prior to four consecutive operant sessions (Fig. 1). Rats then 
received 4 consecutive sessions of ethanol operant access to assess for carryover effects of 
LY (Fig. 1).
Statistical analyses
Overall operant responding (60 min) data were analyzed with a mixed factorial analysis of 
variance (ANOVA) with a between-subject factor of “dose” and a repeated measure of 
“session.” For the PSR experiments, the baseline measure for the factor of “session” was the 
average number of responses on the ethanol lever for the last three extinction sessions. For 
the deprivation studies, the baseline measure for the factor of “session” was the average 
number of responses on the ethanol lever for the three sessions immediately prior to the 
extinction phase. Baseline measure for the maintenance experiment was the three sessions 
immediately prior to NAL or LY testing.
Results
Effects of NAL administration on ethanol PSR/relapse/maintenance responding
For the PSR test, responses on the ethanol lever were lower in the NAL-treated rats than in 
the saline group (Fig. 2). Examining the number of responses on the lever previously 
associated with the delivery of ethanol indicated a significant effect of “session” (F[4, 25] = 
42.2; P < .001), “dose” (F[3, 28] = 4.7; P = .009), and a “session” by “dose” interaction 
(F[12, 81] = 2.9; P < .001). Decomposing the interaction term by performing individual 
ANOVAs on each session indicated that there was a significant effect of “dose” during the 
initial PSR session (F[3, 28] = 12.7; P < .001). Post hoc comparisons indicated that saline-
treated rats responded more than all other groups, and that rats treated with 1 or 5 mg/kg 
responded more than rats treated with 10 mg/kg NAL. Additionally, compared with 
extinction baseline levels, the amount of responding on the lever associated with the 
delivery of ethanol was significantly higher during the initial PSR test session in rats 
administered saline, 1 or 5 mg/kg NAL (P values < .001). Compared with saline levels, 
NAL reduced responses on the ethanol lever by 39% at 1 mg/kg, 37% at 5 mg/kg, and 70% 
at 10 mg/kg during the first PSR session. During PSR sessions 2–4, responses on the ethanol 
lever for all groups (saline and NAL) were similar and not significantly different than 
extinction baseline (Fig. 2). Responding on the lever previously associated with water was 
not significantly different between extinction (7.6 ± 1.3 responses/session) and PSR testing 
(9.3 ± 2.2: Session F[4, 25] = 2.6, P = .066; Session × Group F[12, 81] = 1.3, P = .23; 
Group F[3, 28] = 0.4, P = .77).
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For the relapse test (Fig. 3), responses on the ethanol lever were lower for the NAL-treated 
rats than for the saline group. There was no evidence that previous treatment with NAL 
influenced subsequent treatment with NAL (carryover effect; all P values > .45); therefore, 
this variable was not included in the final analysis. Examining the number of responses on 
the ethanol lever indicated a significant effect of “session” (F[4, 25] = 23.3; P < .001) 
“dose” (F[3, 28] = 45.4; P < .001), and a “session” by “dose” interaction (F[12, 81] = 2.9; P 
= .002). Individual ANOVAs performed on each of the four injection/relapse days revealed 
that NAL reduced responding for ethanol across all four sessions (“dose”—F values [3, 28] 
> 16.8; P values < .001). Post hoc comparisons indicate that saline-treated rats responded 
more than all other groups during each relapse session tested. Additionally, saline-treated 
rats responded more for ethanol during the first relapse session compared with baseline 
values (P = .004). During subsequent sessions, responses on the ethanol lever by the saline 
group were not different from baseline (Fig. 3). Responding on the water lever was not 
significantly different between baseline (8.2 ± 1.1) and relapse testing (9.3 ± 0.8: Session 
F[4, 25] = 1.2, P = .46; Session × Group F[12, 81] = 1.4, P = .17; Group F[3, 28] = 2.4, P 
= .088). After treatment, responding on the ethanol lever for the NAL groups returned to 
control levels (Fig. 3).
NAL also reduced responding on the ethanol lever under maintenance conditions (Fig. 4). 
There was a significant effect of “session” (F[4, 52] = 61.1; P < .001), “dose” (F[3, 28] = 
19.8; P < .001), and a “session” by “dose” interaction (F[12, 81] =3.7; P < 001). Individual 
ANOVAs performed on each of the four treatment days revealed that NAL reduced 
responding for ethanol across all four sessions (“dose”—F values [3, 28] > 6.3; P values < .
002). Post hoc comparisons indicated that saline-treated rats responded more than all other 
groups during the first, second, and third injection sessions. During the fourth injection 
session, saline-treated rats responded more than rats treated with the two highest doses of 
NAL. Additionally, the 1 and 5 mg/kg NAL-treated rats had higher responding on the 
ethanol lever than the 10 mg/kg NAL groups in the fourth injection session. There were no 
group differences for ethanol responding during the postinjection sessions (P values > .51). 
Responding on the water lever was low (14.5 ± 2.3 responses/session), and was not 
significantly altered by NAL during maintenance testing (10.9 ± 2.7: data not shown, P 
values > .66).
Effects of LY administration on ethanol PSR/relapse/maintenance responding
Overall, LY reduced or completely inhibited responding on the ethanol lever during the PSR 
test (Fig. 5) Examining the number of responses on the lever previously associated with the 
delivery of ethanol indicated a significant effect of “session” (F[4, 32] = 6.0; P < .001), 
“dose” (F[4, 35] = 6.9; P < .001), and a “session” by “dose” interaction (F[16, 140] = 3.7; P 
< .001). Decomposing the interaction term by performing individual ANOVAs on each 
session indicated that there was a significant effect of “dose” during the initial PSR session 
(F[4, 35] = 19.3; P < .001). Post hoc comparisons indicated that rats administered vehicle or 
0.03 mg/kg LY responded more during the initial PSR test session compared with extinction 
baseline values than rats administered 0.1, 0.3, or 1 mg/kg LY (P values < .001). 
Responding on the lever previously associated with water was not significantly altered 
between extinction baseline (12.9 ± 2.1 responses/session) and PSR testing (10.0 ± 1.4). 
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Statistically, there was no effect of Session (F[4, 32] = 1.33; P = .28), Group (F[4, 35] = 
1.26; P = .31), or Session × Group interaction (F[16, 140] = 1.3; P = .21).
LY reduced responding on the ethanol lever by P rats across all four sessions under relapse 
conditions (Fig. 6). There was no statistical evidence that previous treatment with LY 
influenced subsequent treatment with LY (carryover effect; all P values > .52). Therefore, 
this variable was not included in the final analysis. Examining the number of responses on 
the ethanol lever (Fig. 6) indicated a significant effect of “session” (F[4, 32] = 42.5; P < .
001), “dose” (F[4, 35] = 23.5; P < .001), and a “session” by “dose” interaction (F[16, 140] = 
3.8; P < .001). Individual ANOVAs performed on each of the four injection/reinstatement 
days revealed that LY reduced responding for ethanol across all four sessions (“dose”—F 
values [4, 35] > 5.7; P values < .001). Post hoc comparisons indicated that vehicle-treated 
rats responded more than all other groups for the first three relapse sessions, and more than 
rats treated with 0.1, 0.3, or 1 mg/kg LY during the fourth relapse session. Individual 
ANOVAs performed on the three postinjection sessions indicated no significant group 
differences (P values > .08). Responding on the water lever was not significantly different 
between baseline (10.7 ± 3.7 responses/session) and relapse levels (16.7 ± 4.2).
LY reduced responding on the ethanol lever under maintenance conditions also (Fig. 7). 
There was an effect of “session” (F[4, 32] = 31.8; P < .001), “dose” (F[4, 35] = 21.5; P < .
001), and a “session” by “dose” interaction (F[16, 140] = 2.9; P < .001). Individual 
ANOVAs performed on each of the four injection days revealed that LY dose dependently 
reduced responding for ethanol across all four sessions (“dose”—F values [4, 35] > 9.3; P 
values < .001). Post hoc comparisons indicated that vehicle-treated rats responded more than 
all LY groups during the first three injection sessions and responded more than the 0.1, 0.3, 
and 1.0 mg/kg LY groups in the fourth injection session. There were no group differences 
for ethanol responding during the postinjection sessions (P values > .12). Responding on the 
water was not significantly altered between baseline (11.2 ±1.2 responses/session) and 
maintenance testing (9.5 ± 1.7). Statistically, there was no effect of Session (F[4, 32] = 0.85; 
P = .5), Group (F[4, 35] = 1.6; P = .19), or Session × Group interaction (F[16, 140] = 1.5; P 
= .11).
Discussion
The current data indicate that the opioid antagonists, NAL and LY, decrease seeking, 
relapse, and maintenance responding for ethanol in adult female P rats, with LY being 100 
times more potent than NAL at blocking seeking behavior. For both drugs, the lowest dose 
was twice as effective at reducing relapse responding (80–90% for NAL and 70% for LY) 
than seeking (40% for NAL and 35% for LY), suggesting that the opioid mechanisms 
underlying seeking and relapse are different. LY was three times more effective at reducing 
relapse than maintenance, suggesting a different mechanism underlying these two behaviors. 
Overall, these results suggest that opioid receptors are involved in ethanol reinforcement, 
and that opioid mechanisms underlying seeking, relapse, and maintenance responding may 
be different.
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It should be noted that the doses of NAL that were necessary to block PSR in P rats in our 
experiment were much higher than the doses necessary to block seeking in other rat models. 
For example, a 1 mg/kg dose of NAL was sufficient to block cue-induced ethanol-seeking 
behavior in Wistar rats (Ciccocioppo et al., 2003; Dayas et al., 2007; Liu and Weiss, 2002), 
and only 0.2 mg/kg dose of NAL was necessary to block ethanol priming-induced 
reinstatement of ethanol self-administration in Wistar rats (Lê et al., 1999). In another model 
of ethanol seeking in Wistar rats, where ethanol-associated cues induced an increase in 
ethanol consumption, this increase was blocked with a 1 mg/kg dose of NAL (Pickering and 
Liljequist, 2003). Reinstatement of ethanol-seeking behavior induced by an exposure to 
ethanol-associated cues was blocked with administration of 10 mg/kg of NAL in Long-
Evans rats (Williams and Schimmel, 2008). In our rat model of alcohol seeking, a 10 mg/kg 
dose of NAL was necessary to completely block the ethanol-seeking behavior. Although 1 
and 5 mg/kg doses of NAL resulted in a decrease in ethanol seeking, these doses did not 
completely block the ethanol-seeking behavior. The reason why NAL needed to be at a 
higher dose to block seeking behavior in P rats than Wistar rats might either have to do with 
the nature of the behavioral test (i.e., reinstatement vs. PSR), with a difference between the 
two rat strains in the affinity of the opioid receptors for NAL, and/or a result of ethanol 
being a stronger reinforcer in P rats than in Wistar rats. Unlike NAL, LY was capable of 
completely blocking ethanol-seeking behavior at 0.1 mg/kg. The results indicate that PSR in 
the P rat is a robust model of ethanol-seeking behavior, and LY is over 100 times more 
potent than NAL at blocking this seeking behavior.
It should be pointed out that built into the design of the relapse experiments, there is over a 
5-week period of abstinence in which the rats do not consume alcohol. Although the 
possibility exists that what appears to be an increase in consumption as a result of 
deprivation is in fact merely an alteration in baseline consumption over time, several studies 
(reviewed in Rodd et al., 2004) indicate that baseline consumption, in similar operant 
conditions as the present study, is stable and does not increase over a period of several 
weeks (Toalston et al., 2008). With regard to the effect of treatment on baseline self-
administration, because the saline-treated rats increase ethanol self-administration from 
baseline and the treatments reduced self-administration compared with saline, it can be 
concluded that NAL and LY are inhibiting ethanol self-administration under relapse 
conditions.
It was necessary to use high doses of NAL to observe effects under the present conditions. 
However, it is possible that, at these doses, there might be some nonspecific effects of the 
drugs on other behaviors, such as aversion or general motor activity. Although the responses 
on the water lever were low (10–15 responses/session), the finding that NAL or LY did not 
reduce responses suggest that the high doses of NAL or LY were not having a major effect 
on gross motor activity. There have been studies indicating that NAL can induce a 
conditioned taste aversion (CTA) in nonhuman primates at a dose of 0.32 mg/kg (Williams 
and Woods, 1999), and a conditioned place aversion (CPA) at a dose of 10 mg/kg in albino 
CFW mice (Bespalov et al., 1999) and Sprague–Dawley rats (Parker and Rennie, 1992). In 
an elegant study, Mitchell et al. (2009) demonstrated that Lewis rats with experience with 
ethanol, when given a subcutaneous injection of 3 mg/kg NAL, showed a CPA to NAL that 
correlated positively with the amount of ethanol consumed. Rats that showed a strong CPA, 
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consumed the highest level of ethanol. Rats that consumed moderate amounts of ethanol 
showed no aversion, and rats that showed low amounts of ethanol consumption, 
demonstrated a slight conditioned place preference. Interestingly, this correlation was only 
present if the rats had experience with consuming ethanol prior to the CPA testing. Rats that 
were ethanol naïve prior to CPA testing showed no correlation between level of aversion to 
NAL and amount of ethanol consumed; In addition, the level of aversion was slight in the 
majority of rats. It was also shown in this study that passive administration of two different 
doses of ethanol (in two separate groups) 1.5 h prior to NAL injection (given immediately 
before NAL aversion training) did not correlate with level of CPA seen in these rats, 
indicating that the high level of aversion seen in the high ethanol consuming rats is not 
purely due to the pharmacological effects of ethanol.
Several additional studies have shown that NAL, at certain doses in certain strains of rat in 
certain conditions, does not produce a CPA. For example, administration of NAL at doses as 
high as 3 mg/kg did not induce CPA in either Wistar rats (Häggkvist and Lindholm, 2009) 
or Spraguee–Dawley rats (White et al., 2005). In the latter study (White et al., 2005), NAL 
induced CPA only if administered after passive intraperitoneal administration of morphine. 
To date, there have been no studies to determine if NAL given to P rats is aversive at a dose 
of 10 mg/kg as measured by CPA or CTA. There are data, however, indicating that P rats 
given doses of NAL as high as 30 mg/kg did not decrease food or water consumption (Sable 
et al., 2006), thus suggesting that NAL does not induce gross aversion at doses as high as 30 
mg/kg.
It should be pointed out that most of the background studies cited in the Introductory section 
used male rats. To control for the possibility that the estrous cycle may have an effect on 
ethanol-associated behaviors, female rats were housed in the same colony room as male rats 
ensuring that the estrous cycle among females was not synchronized, thus helping to control 
for effects of estrous cycle on behavior. One study by Sable et al. (2006) carried out in both 
adolescent and adult male and female P rats, demonstrated no difference in the effect of 
NAL on alcohol consumption levels between the sexes. Thus, it can be concluded that the 
results presented in this article may be applicable to both sexes.
LY is a nonspecific opioid receptor antagonist belonging to a family of antagonists referred 
to as the 3,4-dimethyl-4-(3-hydroxyphenyl)piperidines (Emmerson et al., 2004). It has been 
shown that there is no LY binding in mouse brain sections incubated in the presence of NAL 
(Gackenheimer et al., 2005), suggesting common binding sites between the two drugs, 
which would explain the similarities in the results observed in the present study. In a series 
of experiments carried out by Emmerson et al. (2004), it was determined that the presence of 
Na+ had an effect on LY binding affinity to the opioid receptors, but had no effect on NAL 
binding affinity to these receptors. Addition of Na+ increased the binding affinity of LY by 
sixfold at the mu-opioid receptor from a Ki of 0.32 ± 0.03 to 0.051 ± 0.006 nM, 12-fold at 
the kappa-opioid receptor from a Ki of 10.3 ± 2.9 to 0.82 ± 0.14 nM, and 34-fold at the 
delta-opioid receptor from 151 ± 47 to 4.44 ± 0.52 nM. Comparison of the rank order of 
opioid receptor antagonist affinity under low Na+ conditions established that LY was 
equipotent with NAL at the mu-opioid receptor and 10-fold less potent at the kappa- and 
delta-opioid receptors. In the presence of Na+, LY was 10-fold more potent than NAL at the 
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mu-opioid receptor and twofold more potent at the kappa- and delta-opioid receptors. Such 
differences in mu-, delta-, and kappa-opioid receptor binding affinities might explain the 
difference seen between NAL and LY regarding potency in blocking ethanol seeking.
Differences between the pharmacokinetics of NAL and LY are small, with LY having a 
half-life of 1.5 h (Swanson et al., 1995) and NAL having a half-life of 1 h (Akala et al., 
2008). Thus, it can be stated that the differences seen in the behavioral effects of these drugs 
on seeking, relapse, and maintenance cannot be explained in terms of pharmacokinetic 
differences.
Besides differences in opioid receptor affinity, another important difference between NAL 
and LY that might explain some of the behavioral differences are that LY has inverse 
agonist activity in conditions that NAL does not (Emmerson et al., 2004). This was indicated 
by a decrease in GTPγS binding induced by LY that was not induced by NAL (Emmerson et 
al., 2004). However, under certain conditions, NAL does exhibit inverse agonist activity. 
For example, NAL behaved as a neutral antagonist only in membranes from vehicle-treated 
cells and mice, but acted as an inverse agonist in membranes from morphine-and ethanol-
treated cells in vitro, and morphine-treated mice in vivo (Marczak et al., 2007; Wang et al., 
2001, 2007). Overall, it can be concluded that the conditions under which LY and NAL act 
as inverse agonists differ. Thus, it is possible that the differences seen between the drugs 
with respect to potency may be due to differences in inverse agonist activity.
Naloxone, a nonselective opioid antagonist, has also been shown to reduce 2-h limited 
access ethanol intake in P rats under relapse conditions (i.e., after 2 weeks of ethanol 
deprivation) (Badia-Elder et al., 1999). This result is consistent with the present study that, 
NAL blocked relapse in P rats, induced by 2 weeks of ethanol deprivation, at doses as low as 
1 mg/kg. A recent study conflicted with our own, for it found that a 20 mg/kg dose of NAL 
did not block relapse in the inbred P rat (Rezvani et al., 2009). The reason for the 
discrepancy may be due to a number of factors. For instance, in our study, the rats drank in a 
1-h limited access operant procedure, and in the study by Rezvani et al. (2009), the rats were 
exposed to alcohol for 24 h in a free-bottle choice procedure. Another major difference 
between the two studies was in the amount of time given for ethanol deprivation. In our 
study, 2 weeks of deprivations was given, while in the study by Rezvani et al., 1 day was 
given.
As summarized in the introduction, NAL has been reported to reduce alcohol drinking in 
humans, nonhuman primates, rat lines selectively bred for high-alcohol consumption, in 
genetically heterogenous rats, and in B6 mice. These results are consistent with those found 
in the present study, which showed that NAL decreased the maintenance of ethanol self-
administration in the P rat. Results from the present study also indicated that LY decreased 
the maintenance of ethanol self-administration, which is consistent with other studies in the 
literature, indicating that other nonselective opioid antagonists also have a suppressant effect 
on ethanol consumption. One of the differences between NAL and LY could be seen on the 
first day of drug administration during maintenance self-administration, where the highest 
dose of NAL used (10 mg/kg) decreased self-administration, whereas the highest dose of LY 
used (1 mg/kg) completely blocked ethanol self-administration. Another difference between 
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NAL and LY was that 1 mg/kg NAL lost effectiveness on the fourth day of treatment, 
whereas 0.1 mg/kg LY maintained its effectiveness. P rats have shown the development of 
tolerance to the effect of NAL over days (Rezvani et al., 2007; Sable et al., 2006). On the 
whole, the results indicate that the opioid receptor system is involved in maintaining alcohol 
consumption and self-administration behaviors in both limited and free-access procedures.
In conclusion, our findings indicate that the opioid system is involved in alcohol seeking, 
relapse, and maintenance responding in the P rat, as indicated by the ability of the opioid 
antagonists NAL and LY to decrease these three behaviors. However, LY was more potent 
than NAL at reducing responding during seeking, relapse, and maintenance.
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Fig. 1. 
Depicts the timeline in which the rats proceed through the Pavlovian Spontaneous Recovery 
(PSR), relapse, and maintenance procedures.
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Fig. 2. 
Depicts the mean (±standard error of the mean) responses/session on the lever previously 
associated with the delivery of ethanol in alcohol-preferring (P) rats (n = 8/group) given 0, 1, 
5, or 10 mg/kg naltrexone (NAL) subcutaneously 30 min prior to the four Pavlovian 
Spontaneous Recovery (PSR) session. *Indicates that saline and 1 or 5 mg/kg NAL-treated 
rats responded significantly more on the ethanol lever during the first PSR session compared 
with baseline levels.
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Fig. 3. 
Depicts the mean (±standard error of the mean) responses/session on the ethanol lever by 
alcohol-preferring (P) rats (n = 8/group) given 0, 1, 5, or 10 mg/kg naltrexone (NAL) 30 min 
prior to each of the initial four ethanol reexposure session. *Indicates that saline-treated rats 
responded significantly more on the ethanol lever during the first relapse session compared 
with baseline levels, and is significantly higher than all other groups. +Indicate that saline-
treated rats responded for ethanol more than all other groups, but was not different than 
baseline. #Indicates that responses for all NAL doses were lower than baseline.
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Fig. 4. 
Depicts the mean (±standard error of the mean) responses/session on the ethanol lever by 
alcohol-preferring (P) rats (n = 8/group) given 0, 1, 5, or 10 mg/kg naltrexone (NAL) 30 min 
during four consecutive maintenance test sessions. *Indicates that saline-treated rats 
responded significantly more on the ethanol lever than all other groups. +Indicates that 
saline-treated rats responded more for ethanol than did the 5, or 10 mg/kg NAL-treated rats. 
#Indicates responses for all NAL doses were lower than baseline. aIndicates responses for 
the 5 and 10 mg/kg doses are still lower than baseline.
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Fig. 5. 
Depicts the mean (±standard error of the mean) responses/session on the lever previously 
associated with the delivery of ethanol in alcohol-preferring (P) rats (n = 8/group) given 0, 
0.03, 0.1, 0.3, or 1 mg/kg LY255582 (LY) 30 min prior to each of the four Pavlovian 
Spontaneous Recovery (PSR) sessions. *Indicates that vehicle and 0.03 mg/kg LY rats 
responded significantly more on the ethanol lever during the first PSR session compared 
with baseline levels. +Indicates that 0.1 mg/kg group responded significantly more on the 
ethanol lever during the first PSR session compared with baseline levels.
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Fig. 6. 
Depicts the mean (±standard error of the mean) responses/session on the ethanol lever under 
relapse conditions by alcohol-preferring (P) rats (n = 8/group) given 0, 0.03, 0.1, 0.3, or 1 
mg/kg LY255582 (LY) 30 min prior to each of the initial four reexposure sessions. 
*Indicates that rats administered vehicle responded significantly more on the ethanol lever 
during the first reinstatement session compared with baseline levels and significantly more 
than all LY-treated rats. +Indicates that vehicle-treated rats responded more on the ethanol 
lever than all LY-treated rats, but responding was different than baseline. #Indicates that 
vehicle-treated rats responded more than 0.1, 0.3, or 1 mg/kg LY-treated rats. aIndicates that 
all LY were lower than baseline. bIndicates that 0.1, 0.3, and 1.0 LY doses were lower than 
baseline.
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Fig. 7. 
Depicts the mean (±standard error of the mean) responses/session on the ethanol lever under 
maintenance conditions by alcohol-preferring (P) rats (n = 8/group) given 0, 0.03, 0.1, 0.3, 
or 1 mg/kg LY255582 (LY) 30 min prior to maintenance test sessions. *Indicates that rats 
administered vehicle or 0.03 mg/kg LY responded significantly more on the ethanol lever 
than other LY-treated rats. +Indicates that vehicle-treated rats responded more than all LY-
treated rats, and that 0.03 mg/kg LY-treated rats responded more than all other LY-treated 
rats. #Indicates that 0.1, 0.3, and 1.0 LY groups had lower responses than baseline.
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